Avidity Biosciences Inc (RNA)
52.12
-0.43
(-0.82%)
USD |
NASDAQ |
Nov 14, 10:26
Avidity Biosciences Market Cap: 6.104B for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.155B |
| November 12, 2024 | 5.473B |
| November 11, 2024 | 5.519B |
| November 08, 2024 | 5.472B |
| November 07, 2024 | 5.564B |
| November 06, 2024 | 5.533B |
| November 05, 2024 | 5.281B |
| November 04, 2024 | 5.249B |
| November 01, 2024 | 4.904B |
| October 31, 2024 | 4.950B |
| October 30, 2024 | 5.062B |
| October 29, 2024 | 5.220B |
| October 28, 2024 | 5.355B |
| October 25, 2024 | 5.283B |
| October 24, 2024 | 5.288B |
| October 23, 2024 | 5.317B |
| October 22, 2024 | 5.549B |
| October 21, 2024 | 5.471B |
| October 18, 2024 | 5.909B |
| October 17, 2024 | 5.683B |
| October 16, 2024 | 5.732B |
| October 15, 2024 | 5.470B |
| October 14, 2024 | 5.471B |
| October 11, 2024 | 5.458B |
| October 10, 2024 | 5.179B |
| Date | Value |
|---|---|
| October 09, 2024 | 5.359B |
| October 08, 2024 | 5.426B |
| October 07, 2024 | 5.147B |
| October 04, 2024 | 5.540B |
| October 03, 2024 | 5.511B |
| October 02, 2024 | 5.519B |
| October 01, 2024 | 5.682B |
| September 30, 2024 | 5.379B |
| September 27, 2024 | 4.958B |
| September 26, 2024 | 4.939B |
| September 25, 2024 | 5.382B |
| September 24, 2024 | 5.153B |
| September 23, 2024 | 5.095B |
| September 20, 2024 | 5.210B |
| September 19, 2024 | 5.347B |
| September 18, 2024 | 5.227B |
| September 17, 2024 | 4.941B |
| September 16, 2024 | 4.890B |
| September 13, 2024 | 4.885B |
| September 12, 2024 | 4.838B |
| September 11, 2024 | 4.748B |
| September 10, 2024 | 4.777B |
| September 09, 2024 | 4.774B |
| September 06, 2024 | 4.739B |
| September 05, 2024 | 4.774B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
360.87M
Minimum
Oct 27 2023
6.155B
Maximum
Nov 13 2024
1.424B
Average
983.73M
Median
Jan 05 2022
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 10.60B |
| Natera Inc | 19.78B |
| Entrada Therapeutics Inc | 729.41M |
| Alnylam Pharmaceuticals Inc | 33.62B |
| Catalyst Pharmaceuticals Inc | 2.605B |
Market Cap Related Metrics
| PS Ratio | 423.30 |
| Price to Book Value | 4.999 |
| Price | 52.12 |
| Earnings Yield | -5.66% |